| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2174/187152910790780096 |
| P8608 | Fatcat ID | release_6dnd4hyka5cnpalzr6fn3iepay |
| P932 | PMC publication ID | 2855626 |
| P698 | PubMed publication ID | 20041838 |
| P5875 | ResearchGate publication ID | 40818831 |
| P2093 | author name string | Raouf A Khalil | |
| Stephanie J Sheppard | |||
| P2860 | cites work | Antihypertensive drug therapy for mild to moderate hypertension during pregnancy | Q24246376 |
| Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups | Q24544895 | ||
| Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia | Q24654029 | ||
| The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia | Q24795491 | ||
| Antioxidant therapy to prevent preeclampsia | Q28171421 | ||
| Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis | Q28191497 | ||
| Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review | Q28196410 | ||
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| Aortic adaptation to pregnancy: elevated expression of matrix metalloproteinases-2 and -3 in rat gestation | Q28574980 | ||
| Impaired angiogenesis in SHR is associated with decreased KDR and MT1-MMP expression | Q28582505 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor | Q30747560 | ||
| Endothelin and nitric oxide mediate reduced myogenic reactivity of small renal arteries from pregnant rats | Q31731441 | ||
| [Ca(2+)](i) signaling in renal arterial smooth muscle cells of pregnant rat is enhanced during inhibition of NOS. | Q31732247 | ||
| Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet | Q32071788 | ||
| Molecular mechanisms of preeclampsia | Q33344105 | ||
| The genetic aspects of pre-eclampsia: achievements and limitations | Q33345506 | ||
| Human genetic selection on the MTHFR 677C>T polymorphism | Q33387977 | ||
| Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation | Q33490821 | ||
| Endothelial cell responses to hypoxic stress | Q33535019 | ||
| Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts | Q45008785 | ||
| Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta | Q45061635 | ||
| Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors | Q45102837 | ||
| Effects of vasoactive agents on intracellular calcium and force in myometrial and subcutaneous resistance arteries isolated from preeclamptic, pregnant, and nonpregnant woman | Q45254319 | ||
| Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. | Q45256231 | ||
| Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks | Q46334260 | ||
| Comparison of intramuscular magnesium sulfate with low dose intravenous magnesium sulfate regimen for treatment of eclampsia | Q46334541 | ||
| Babies, pre-eclamptic mothers and grandparents: a three-generation phenotyping study | Q46339871 | ||
| Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? | Q46342132 | ||
| Discovery of a spontaneous genetic mouse model of preeclampsia | Q46351794 | ||
| Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia | Q46440312 | ||
| Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition | Q46454719 | ||
| Angiotensin-converting enzyme inhibitors reveal non-NO-, non-prostacycline-mediated endothelium-dependent relaxation in internal thoracic artery of hypertensive patients | Q46590537 | ||
| Mechanisms of endothelin-1-induced contraction in pulmonary arteries from chronically hypoxic rats | Q46697023 | ||
| Evidence that inward rectifier K+ channels mediate relaxation by the PGI2 receptor agonist cicaprost via a cyclic AMP-independent mechanism | Q46719781 | ||
| Insulin-like factor 3 levels in amniotic fluid of human male fetuses. | Q46726063 | ||
| Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial | Q46777480 | ||
| Angiotensin II infusion alters vascular function in mouse resistance vessels: roles of O and endothelium | Q46844588 | ||
| Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies | Q46878600 | ||
| Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites | Q46886600 | ||
| The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species | Q46966458 | ||
| Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies | Q46987465 | ||
| Ultrasonographic measurement of thymus size in IUGR fetuses: a marker of the fetal immunoendocrine response to malnutrition | Q47191079 | ||
| The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia | Q47369214 | ||
| Placental trophoblast-derived factors diminish endothelial barrier function | Q47650864 | ||
| Characterization of endothelium- dependent relaxation in guinea pig basilar artery - effect of hypoxia and role of cytochrome P450 mono-oxygenase. | Q47694967 | ||
| Endothelial dysfunction in preeclampsia | Q47879591 | ||
| Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. | Q50514586 | ||
| Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats. | Q50952787 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. | Q51139503 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. | Q51359651 | ||
| Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in pre-eclamptic women. | Q51436935 | ||
| Hypocalcemia and pregnancy-induced hypertension produced by low-calcium diet. | Q51594970 | ||
| A novel mouse model for preeclampsia by transferring activated th1 cells into normal pregnant mice. | Q51816934 | ||
| Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset. | Q51865183 | ||
| Environmental lead level and pregnancy-induced hypertension. | Q51965294 | ||
| Endothelial function in myometrial resistance arteries of normal pregnant women perfused with syncytiotrophoblast microvillous membranes. | Q52055001 | ||
| Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. | Q52170561 | ||
| The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. | Q52515281 | ||
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
| [The role of calcium in the regulation of normal vascular tone and in arterial hypertension] | Q53919958 | ||
| Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. | Q54021736 | ||
| Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients. | Q54515085 | ||
| Rho A/Rho kinase: human umbilical artery mRNA expression in normal and pre eclamptic pregnancies and functional role in isoprostane-induced vasoconstriction. | Q54594222 | ||
| Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. | Q54661322 | ||
| Soluble fms-like Tyrosine Kinase 1 | Q56619509 | ||
| Fine mapping and SNP analysis of positional candidates at the preeclampsia susceptibility locus (PREG1) on chromosome 2 | Q57670256 | ||
| L-Arginine Supplementation in Patients with Gestational Hypertension: A Pilot Study | Q60690363 | ||
| Soluble Flt-1 as a diagnostic marker of pre-eclampsia | Q62504254 | ||
| Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia | Q33679047 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies | Q33930498 | ||
| Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. | Q33940517 | ||
| Placental growth factor is a potent vasodilator of rat and human resistance arteries. | Q34052025 | ||
| Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort | Q34081523 | ||
| Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia | Q34110398 | ||
| Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension | Q34293890 | ||
| Angiotensin and cytoskeletal proteins: role in vascular remodeling | Q34492824 | ||
| World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women | Q34565461 | ||
| Maternal vitamin D deficiency increases the risk of preeclampsia | Q34579840 | ||
| Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia | Q34656275 | ||
| Digibind attenuates cytokine TNFalpha-induced endothelial inflammatory response: potential benefit role of digibind in preeclampsia | Q34707051 | ||
| Hyperglycemia and adverse pregnancy outcomes | Q34777029 | ||
| 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system | Q34793842 | ||
| Nutrient involvement in preeclampsia | Q35121229 | ||
| The genetics of pre-eclampsia: a feto-placental or maternal problem? | Q35177399 | ||
| Enhanced expression of Ang-(1-7) during pregnancy | Q35845564 | ||
| Uric acid as a pathogenic factor in preeclampsia. | Q35868968 | ||
| Angiotensin II and vascular inflammation. | Q36140047 | ||
| Preeclampsia: recent insights | Q36288757 | ||
| Could antioxidant supplementation prevent pre-eclampsia? | Q36325124 | ||
| Fetal programming of hypertension | Q36341270 | ||
| Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. | Q36428553 | ||
| Calcium supplementation during pregnancy and lactation: effects on the mother and the fetus | Q36437354 | ||
| Neurovascular mechanisms of hypertension in pregnancy | Q36486193 | ||
| Intrauterine growth restriction: fetal programming of hypertension and kidney disease | Q36569856 | ||
| Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia | Q36618406 | ||
| Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. | Q36778250 | ||
| Gestational diabetes, pregnancy hypertension, and late vascular disease | Q36862954 | ||
| Diet during pregnancy and risk of preeclampsia or gestational hypertension | Q36867915 | ||
| The glomerular injury of preeclampsia | Q36883342 | ||
| Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. | Q36948563 | ||
| Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction | Q37022723 | ||
| Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. | Q37072792 | ||
| Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia | Q37079628 | ||
| Endoglin in angiogenesis and vascular diseases | Q37088038 | ||
| Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia | Q37119326 | ||
| Altered global gene expression in first trimester placentas of women destined to develop preeclampsia | Q37155561 | ||
| Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia | Q37221219 | ||
| Searching for genetic factors underlying pre-eclampsia: recent progress and persistent challenges. | Q37293822 | ||
| Obesity, gestational diabetes and pregnancy outcome | Q37300560 | ||
| Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
| Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats | Q37449704 | ||
| Human-specific expression of Siglec-6 in the placenta | Q38300677 | ||
| Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways | Q38351435 | ||
| The impact of maternal obesity on maternal and fetal health | Q40007232 | ||
| Mitochondrial reactive oxygen species and c-Src play a critical role in hypoxic response in vascular smooth muscle cells | Q40418046 | ||
| Paradoxical Elevation in Adiponectin Concentrations in Women With Preeclampsia | Q40559156 | ||
| Effects of placental proteases on maternal and fetal blood pressure in normal pregnancy and preeclampsia | Q41092408 | ||
| Mechanisms of smooth muscle contraction | Q41169589 | ||
| Resistance artery smooth muscle function in pregnancy and preeclampsia | Q42516324 | ||
| Nitric oxide synthase activity in placentae from women with pre-eclampsia | Q42520050 | ||
| Alterations in the renin-angiotensin system in a rat model of human preeclampsia | Q43218182 | ||
| Stabilization of hypoxia-inducible factor-1{alpha} by prostacyclin under prolonged hypoxia via reducing reactive oxygen species level in endothelial cells. | Q43413808 | ||
| Association of maternal endothelial dysfunction with preeclampsia | Q43553727 | ||
| Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. | Q43576536 | ||
| Regulation of prostacyclin synthesis by angiotensin II and TNF-alpha in vascular smooth muscle | Q43577316 | ||
| Elevated levels of S-nitrosoalbumin in preeclampsia plasma | Q43633772 | ||
| High intake of energy, sucrose, and polyunsaturated fatty acids is associated with increased risk of preeclampsia | Q43717221 | ||
| The role of endothelium-derived hyperpolarizing factor in the regulation of the uterine circulation in pregnant rats | Q43745798 | ||
| Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre-eclampsia | Q43872581 | ||
| Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats | Q43888051 | ||
| Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia | Q44048792 | ||
| Folic acid supplementation in early second trimester and the risk of preeclampsia | Q44054579 | ||
| Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats | Q44130345 | ||
| Enhanced [Ca2+]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure | Q44185600 | ||
| Reduced function of endothelial prostacyclin in human omental resistance arteries in pre-eclampsia | Q44218040 | ||
| Association between 894G>T endothelial nitric oxide synthase gene polymorphisms and metabolic syndrome | Q44401791 | ||
| Pulmonary vascular endothelial growth factor and nitric oxide interaction during total cardiopulmonary bypass in neonatal pigs | Q44456864 | ||
| Tumor necrosis factor alpha in the bovine oviduct during the estrous cycle: messenger RNA expression and effect on secretion of prostaglandins, endothelin-1, and angiotensin II. | Q44475138 | ||
| Pre-eclampsia (EPH-gestosis)-induced decrease of MMP-s content in the umbilical cord artery | Q44555376 | ||
| The M235T variant of the angiotensinogen gene is related to development of self-reported hypertension during pregnancy: the Prospect-EPIC cohort study | Q44632633 | ||
| Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats | Q44715072 | ||
| Low socioeconomic status is a risk factor for preeclampsia: the Generation R Study | Q44750267 | ||
| Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia | Q44897228 | ||
| The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood | Q44929427 | ||
| Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia | Q64377002 | ||
| Pre-eclampsia and trisomy 13 | Q67592481 | ||
| Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment | Q68053902 | ||
| Pre-eclampsia and trisomy 13: a possible association | Q69904752 | ||
| Protein kinase C in uterine and systemic arteries during ovarian cycle and pregnancy | Q70116950 | ||
| Chronic hypoxia selectively augments endothelium-dependent pulmonary arterial vasodilation | Q71465109 | ||
| Ca(2+)-insensitive vascular protein kinase C during pregnancy and NOS inhibition | Q73087551 | ||
| Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery | Q73258662 | ||
| Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia | Q73399793 | ||
| Pregnancy-associated reduction in vascular protein kinase C activity rebounds during inhibition of NO synthesis | Q73426782 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia | Q74226798 | ||
| Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy | Q74253964 | ||
| Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats | Q74518978 | ||
| Nitric oxide production with preeclampsia | Q74601245 | ||
| Circulating levels of immunoreactive cytokines in women with preeclampsia | Q77384781 | ||
| Peripheral blood mononuclear cells stimulate progesterone production by luteal cells derived from pregnant and non-pregnant women: possible involvement of interleukin-4 and interleukin-10 in corpus luteum function and differentiation | Q77519168 | ||
| Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression | Q77684136 | ||
| Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats | Q77755765 | ||
| Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats | Q77945719 | ||
| Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet | Q78009520 | ||
| Purification and characterization of a complex from placental syncytiotrophoblast microvillous membranes which inhibits the proliferation of human umbilical vein endothelial cells | Q78018453 | ||
| Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy | Q78117582 | ||
| Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs | Q78396702 | ||
| Angiotensin-(1-7) in normal and preeclamptic pregnancy | Q78568866 | ||
| Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study | Q79397360 | ||
| Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors | Q80425329 | ||
| Serum levels of interleukin-6, interleukin-1beta and human chorionic gonadotropin in pre-eclamptic and normal pregnancy | Q80454204 | ||
| Pre-eclampsia: clinical manifestations and molecular mechanisms | Q80482285 | ||
| Recent patents on Rho signaling pathway as therapeutic target for cardiovascular diseases | Q80551190 | ||
| The immunohistochemical evaluation of VEGF in placenta biopsies of pregnancies complicated by preeclampsia | Q80821578 | ||
| Relationship between increased blood lead and pregnancy hypertension in women without occupational lead exposure in Tehran, Iran | Q80991877 | ||
| Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast | Q81086992 | ||
| Generation of reactive oxygen species by neutrophils and endothelial cell injury in normal and preeclamptic pregnancies | Q81236313 | ||
| Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction | Q81305565 | ||
| Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood | Q81432957 | ||
| Dietary fiber, potassium, magnesium and calcium in relation to the risk of preeclampsia | Q81878607 | ||
| Calcium supplementation for the prevention of pre-eclampsia | Q82283234 | ||
| P433 | issue | 1 | |
| P921 | main subject | hypertension | Q95566669 |
| P304 | page(s) | 33-52 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Cardiovascular & hematological disorders drug targets | Q26867051 |
| P1476 | title | Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy | |
| P478 | volume | 10 |
| Q54588260 | Angiogenin and hemoxygenase in pregnancy: influence of hypertension. |
| Q37709091 | Association of inflammatory cytokines, lipid peroxidation end products and nitric oxide with the clinical severity and fetal outcome in preeclampsia in Indian women |
| Q48717665 | Biochemical markers of placental dysfunction in assisted conception |
| Q31143639 | Co-expression network analysis and genetic algorithms for gene prioritization in preeclampsia |
| Q36192139 | Contribution of TIMP3 polymorphisms to the development of preeclampsia in Han Chinese women |
| Q56996369 | Disruption in the Regulation of Immune Responses in the Placental Subtype of Preeclampsia |
| Q37019600 | Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia |
| Q36268948 | Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy |
| Q36409599 | Immune Mechanisms Linking Obesity and Preeclampsia |
| Q39973331 | Maternal and fetal outcome in women with gestational hypertension in comparison to gestational proteinuria: A 3-year observational study. |
| Q39005279 | Maternal plasma TIMP-4 levels combined with clinical risk factors for the early prediction of pregnancy-induced hypertension |
| Q37993746 | Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications |
| Q58589187 | Molecular Determinants of Microvascular Dysfunction in Hypertensive Pregnancy and Preeclampsia |
| Q97525718 | Postpartum Pulmonary Hypertension Masquerading as Submassive Pulmonary Embolism: A Case Report and a Literature Review |
| Q37990465 | Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk |
| Q34370899 | Preeclampsia: a bioinformatics approach through protein-protein interaction networks analysis |
| Q36748065 | Protein Kinase C Inhibitors as Modulators of Vascular Function and their Application in Vascular Disease |
| Q26828020 | Role of endothelin in uteroplacental circulation and fetal vascular function |
| Q83963760 | [Pregnancy-linked endotheliopathy. A disease with multiple variants?] |
| Q33760840 | eNOS activation and NO function: pregnancy adaptive programming of capacitative entry responses alters nitric oxide (NO) output in vascular endothelium--new insights into eNOS regulation through adaptive cell signaling |
Search more.